One company's optionality is another company's threat. For Teladoc (TDOC -2.91%) and Amwell (AMWL 1.07%), that threat could come from Zoom (ZM -0.99%).
In this Backstage Pass video, which aired Sept. 28, 2021, Motley Fool analyst Yasser El-Shimy shares his thoughts.
10 stocks we like better than Teladoc Health
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Teladoc Health wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of September 17, 2021
Yasser El-Shimy: Can I just jump in here for a second while we still have this slide?
Jon Quast: Sure. Absolutely.
El-Shimy: I just wanted to comment that not a lot of people actually are aware of that Zoom is a serious player in telehealth. That's one of the industry verticals where they are doing a lot of really successful work.
Usually when we think telehealth, of course, that's just Teladoc or Amwell. But Zoom Health is HIPAA compliant.
It's a very easy solution to use for a lot of doctors, a lot of hospitals, clinics, practices and so on. Just put it on and start engaging with their patients without having to go through a third-party like a Teladoc or Amwell.
I just wanted to highlight that. Thanks, Jon.
